You are here

Article Text

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Does IL-38 act on macrophages and/or dendritic cells in arthritis?’ by Jiang et al
  1. Marie-Astrid Boutet,
  2. Frédéric Blanchard,
  3. Benoît Le Goff
  1. INSERM UMR1238 (ex UMR957), Université de Nantes, Nantes University Hospital, Nantes, France
  1. Correspondence to Dr Frédéric Blanchard and Pr Benoît Le Goff, INSERM UMR1238 (ex UMR957), Université de Nantes, Nantes University Hospital, 44035 Nantes, France; frederic.blanchard{at}univ-nantes.fr, benoit.legoff{at}chu-nantes.fr

https://doi.org/10.1136/annrheumdis-2017-211793

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We appreciate the comments by Jiang et al 1 on our study showing that IL-38 overexpression has anti-inflammatory effects in experimental arthritis presumably through decreased production of proinflammatory cytokines by macrophages.2 Jiang et al point out that the Iba1 marker used in our immunohistochemistry analysis is also expressed by dendritic cells (DCs) and that IL-23, whose expression is reduced by IL-38, is also highly expressed by DCs. Therefore, IL-38 could target DCs in addition to macrophages.

    Ionised calcium-binding adaptor molecule 1 (Iba1) also known as allograft inflammatory factor 1 (AIF-1) is widely accepted as a pan-macrophage marker expressed in …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles